|
Yale Cancer Center NCTN
|
5U10CA180826-05
|
$700,035
|
$35,002
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$91,803
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$5,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$2,725
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$1,514
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$635
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S1
|
$247,355
|
$4,947
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S2
|
$35,000
|
$700
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S3
|
$124,862
|
$2,497
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S4
|
$48,726
|
$975
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S5
|
$174,039
|
$3,481
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S6
|
$107,460
|
$2,149
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
5P30CA044579-27
|
$2,599,349
|
$51,987
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-30S3
|
$223,326
|
$6,700
|
SCHULICK, RICHARD
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
5P30CA046934-30
|
$3,853,226
|
$115,597
|
SCHULICK, RICHARD
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-30S1
|
$39,685
|
$1,191
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-30S2
|
$243,547
|
$7,306
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Trinity Field Study
|
ZIA CP010185 10694
|
$259,499
|
$155,699
|
Simon, Steven
|
DCEG (NCI)
|
|
Treatment decision making in low-risk thyroid cancer
|
5R01CA201198-03
|
$518,509
|
$518,509
|
HAYMART, MEGAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Thyroid Tumor Sequencing study (Ukraine)
|
ZIA CP010132 10650
|
$101,333
|
$101,333
|
Morton, Lindsay
|
DCEG (NCI)
|
|
Thyroid tumor sequencing study (Belarus)
|
ZIA CP010132 10720
|
$30,735
|
$30,735
|
Morton, Lindsay
|
DCEG (NCI)
|
|
Thyroid cancer in Clean-up Workers (Ukraine)
|
ZIA CP010133 10531
|
$50,159
|
$50,159
|
Cahoon, Elizabeth
|
DCEG (NCI)
|
|
The Role of Fragile Sites in RET/PTC Rearrangement
|
5R01CA113863-09
|
$299,516
|
$299,516
|
WANG, YUH-HWA
|
UNIVERSITY OF VIRGINIA
|
|
The Incidence of Breast and other Cancers among Female Flight Attendants
|
ZIA CP010133 04077
|
$16,720
|
$669
|
Little, Mark
|
DCEG (NCI)
|
|
The Chernobyl Tissue Bank - Coordinating Center
|
5U24CA082102-18
|
$324,000
|
$324,000
|
THOMAS, GERALDINE
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
|
TERT Promoter Mutations in Thyroid Cancer
|
5R01CA189224-04
|
$370,575
|
$370,575
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$10,097
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Targeting FAK and Src in thyroid cancer
|
1R01CA222299-01A1
|
$542,360
|
$542,360
|
SCHWEPPE, REBECCA
|
UNIVERSITY OF COLORADO DENVER
|
|
Study to improve thyroid doses from fallout exposure in Kazakhstan
|
ZIA CP010132 10395
|
$24,277
|
$24,277
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
Studies in the Janus Cohort
|
ZIA CP010120 02135
|
$47,817
|
$4,304
|
Rothman, Nat
|
DCEG (NCI)
|
|
SPORE in Thyroid Cancer
|
5P50CA172012-05
|
$2,136,667
|
$2,136,667
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Shanghai prospective cohort study of occupational exposures and cancer risk among
|
ZIA CP010123 02342
|
$65,323
|
$3,266
|
Rothman, Nat
|
DCEG (NCI)
|
|
Selective RET Kinase and Its Mutant Inhibitors for the Treatment of Medullary Thyroid Cancer
|
5R01CA197178-04
|
$284,978
|
$284,978
|
LI, HONG-YU
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Role of p21-activated kinases in thyroid cancer
|
1R01CA227847-01
|
$388,539
|
$388,539
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
Risk factors for thyroid cancer in the NCI cohorts
|
ZIA CP010219 10447
|
$5,159
|
$5,159
|
Kitahara, Cari
|
DCEG (NCI)
|
|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$108,000
|
N/A
|
National Institutes of Health
|
|
Regional Oncology Research Center
|
3P30CA006973-55S1
|
$59,984
|
$1,200
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-55S2
|
$199,060
|
$3,981
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-55
|
$7,069,034
|
$141,381
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Radiobiology Outreach
|
ZIA CP010222 10441
|
$66,403
|
$13,281
|
Berrington, Amy
|
DCEG (NCI)
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 02020
|
$592,688
|
$29,634
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Pooled analysis of radiation-related thyroid cancer
|
ZIA CP010222 10430
|
$66,403
|
$66,403
|
Kitahara, Cari
|
DCEG (NCI)
|
|
Per- and polyfluoroalkyl substances and cancer risk
|
ZIA CP010125 10781
|
$62,232
|
$12,446
|
Jones, Rena
|
DCEG (NCI)
|
|
Pediatric CT Examinations in Israel
|
ZIA CP010222 10543
|
$66,403
|
$6,640
|
Berrington, Amy
|
DCEG (NCI)
|
|
OSU as Network Lead Academic Participating Site for the NCI NCTN
|
5U10CA180850-05
|
$1,311,684
|
$32,792
|
VERSCHRAEGEN, CLAIRE
|
OHIO STATE UNIVERSITY
|
|
Optimization of Treatment of Papillary Thyroid Cancer: A Risk-tailored Approach
|
5K07CA177900-05
|
$142,560
|
$142,560
|
LUBITZ, CARRIE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Oncogenic Events in Thyroid Neoplasia
|
5R01CA072597-19
|
$428,500
|
$428,500
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.
|
1R44CA224376-01A1
|
$285,070
|
$285,070
|
WEINTRAUB, BRUCE
|
TROPHOGEN, INC.
|
|
NICHD_Health Effects of in Utero Exposure to I-131 in Chernobyl Fallout
|
ZIA CP010132 10620
|
$24,277
|
$24,277
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
NIAID_NCI Fallout Dose/Risk Calculator-Programming and Adminsitrative Charges
|
ZIA CP010185 10644
|
$65,633
|
$65,633
|
Simon, Steven
|
DCEG (NCI)
|
Total relevant funding to Thyroid for this search: $13,492,177
|